GSK: Protocol Summaries: Compounds

Quick Search

By Phase:

By Study Type:

By Population:

By Post Marketing Commitment:

By Status:

By Country:

GSK Study ID	Phase	Title	Status
115521	phase 1	A Phase I/II Open-Label, Dose Escalation Study to Investigate the Safety, Pharmacokinetics, Pharmacodynamics, and Clinical Activity of GSK525762 in Subjects with NUT Midline Carcinoma (NMC) and other cancers	Recruiting